Investigational Drug Information for Brilacidin
✉ Email this page to a colleague
What is the drug development status for Brilacidin?
Brilacidin is an investigational drug.
There have been 4 clinical trials for Brilacidin.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 22nd 2021.
The most common disease conditions in clinical trials are Infection, Stomatitis, and Communicable Diseases. The leading clinical trial sponsors are Innovation Pharmaceuticals, Inc., Cellceutix Corporation, and [disabled in preview].
Summary for Brilacidin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 58 |
| WIPO Patent Applications | 49 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2021-02-22) |
| Vendors | 25 |
Recent Clinical Trials for Brilacidin
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | Innovation Pharmaceuticals, Inc. | Phase 2 |
| A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers | Innovation Pharmaceuticals, Inc. | Phase 1 |
| Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer | Cellceutix Corporation | Phase 2 |
Clinical Trial Summary for Brilacidin
Top disease conditions for Brilacidin
Top clinical trial sponsors for Brilacidin
US Patents for Brilacidin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
